The patented SonoChem technology has evolved from a major US$12 million European Union-funded seven nation programme ("SONO"). The programme aimed to develop a method for mass producing low cost antimicrobial textiles using Sonochemistry to produce nanoparticles of these elements.
The SONO consortium used enzymes to improve adhesion of antimicrobial nanoparticles to fabric using ultrasonic irradiation with the ultimate aim of reducing the impact of the significant global health issues associated with the alarming rise of hospital acquired infections (HAIs) affecting patients around the globe.
SonoChem's unique technology leverages from - and improves upon - this ground-breaking European Union work, with significant improvements in the manufacturing process. Further innovation, particularly in relation to scalability, means that SonoChem's technology will enable the mass production of treated textiles, ensuring a potentially global reach of product.
US and EU patents owned by SonoChem will be licensed to its industry partners and will result in the scaled production of a range of items and improved health outcomes on a truly international scale.
The SONO project was initiated to address the urgent need of reducing the growing number of hospital acquired infections in hospitals and healthcare settings across Europe, principally caused by the increasing resistance of pathogens to existing antibiotics.
The project was clinically successful and resulted in the production of highly active antimicrobial textiles. However the machine made to produce these textiles could not achieve production on a commercial scale, and the project did not progress any further.
Two UK-based scientists - Dr Mircea Vinatoru and Professor Tim Mason of Coventry University - commenced the design a new machine that could mass produce antimicrobial textiles, threads and yarns.
A patent application for SonoChem technology was filed in 2015. The application was supported by Coventry University.
Patents for the technology covering Europe and the United States were granted in Aug/Sept 2019.
These patents are owned by SonoChem Limited.
Background information in relation to the scope and findings of the EU SONO Project - a pilot line of antibacterial and antifungal textiles based on a sonochemistry process.
Cordis Report (pdf)
DownloadFor thousands of years, people have known about the disinfectant powers of copper. The use of copper as an infection-killing mechanism is recorded in Smith's Papyrus, the oldest known medical document in history. The document, thought to have been written circa 1700 BC is based on information that dates to 3200 BC.
Research from the University of Southampton has found that copper can effectively help to prevent the spread of respiratory viruses which are linked to severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
A recent clinical study indicates that copper is far better than other common materials at preventing the spread of infectious diseases, including coronavirus. The National Institutes of Health, Centres for Disease Control and Princeton University reported in the New England Journal of Medicine that COVID-19 was "detectable in aerosols for up to three hours, up to four hours on copper, up to twenty-four hours on cardboard and up to two to three days on plastic and stainless steel.
An article published in the Journal of Molecular Pharmaceutics and Organic Process Research considers the use of copper nanoparticles as antibacterial agents.
The magnitude of the global problems associated with antimicrobial resistance were examined in a comprehensive review in 2016.
Copyright © 2023 SonoChem - All Rights Reserved.